These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 18930987

  • 21. Intravascular tumor necrosis factor alpha blockade reverses endothelial dysfunction in rheumatoid arthritis.
    Cardillo C, Schinzari F, Mores N, Mettimano M, Melina D, Zoli A, Ferraccioli G.
    Clin Pharmacol Ther; 2006 Sep; 80(3):275-81. PubMed ID: 16952494
    [Abstract] [Full Text] [Related]

  • 22. Regulation of p38 MAP kinase in CD4+ lymphocytes by infliximab therapy in patients with rheumatoid arthritis.
    Garfield BE, Krahl T, Appel S, Cooper SM, Rincón M.
    Clin Immunol; 2005 Aug; 116(2):101-7. PubMed ID: 15914087
    [Abstract] [Full Text] [Related]

  • 23. Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: effects of tumor necrosis factor-alpha blockade.
    Ingegnoli F, Fantini F, Favalli EG, Soldi A, Griffini S, Galbiati V, Meroni PL, Cugno M.
    J Autoimmun; 2008 Sep; 31(2):175-9. PubMed ID: 18707846
    [Abstract] [Full Text] [Related]

  • 24. Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease.
    Mathieu S, Joly H, Baron G, Tournadre A, Dubost JJ, Ristori JM, Lusson JR, Soubrier M.
    Rheumatology (Oxford); 2008 Aug; 47(8):1203-7. PubMed ID: 18524805
    [Abstract] [Full Text] [Related]

  • 25. Study of the tolerance of infliximab infusions with or without betamethasone premedication in patients with active rheumatoid arthritis.
    Sany J, Kaiser MJ, Jorgensen C, Trape G.
    Ann Rheum Dis; 2005 Nov; 64(11):1647-9. PubMed ID: 16227416
    [Abstract] [Full Text] [Related]

  • 26. Infliximab inhibits bone resorption by circulating osteoclast precursor cells in patients with rheumatoid arthritis and ankylosing spondylitis.
    Gengenbacher M, Sebald HJ, Villiger PM, Hofstetter W, Seitz M.
    Ann Rheum Dis; 2008 May; 67(5):620-4. PubMed ID: 17720725
    [Abstract] [Full Text] [Related]

  • 27. Tumor necrosis factor-alpha monoclonal antibody, infliximab, used to manage severe sciatica.
    Karppinen J, Korhonen T, Malmivaara A, Paimela L, Kyllönen E, Lindgren KA, Rantanen P, Tervonen O, Niinimäki J, Seitsalo S, Hurri H.
    Spine (Phila Pa 1976); 2003 Apr 15; 28(8):750-3; discussion 753-4. PubMed ID: 12698115
    [Abstract] [Full Text] [Related]

  • 28. Polymorphism at position -308 of the tumor necrosis factor alpha gene influences outcome of infliximab therapy in rheumatoid arthritis.
    Mugnier B, Balandraud N, Darque A, Roudier C, Roudier J, Reviron D.
    Arthritis Rheum; 2003 Jul 15; 48(7):1849-52. PubMed ID: 12847678
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Sustained improvement of vascular endothelial function during anti-TNFalpha treatment in rheumatoid arthritis patients.
    Sidiropoulos PI, Siakka P, Pagonidis K, Raptopoulou A, Kritikos H, Tsetis D, Boumpas DT.
    Scand J Rheumatol; 2009 Jul 15; 38(1):6-10. PubMed ID: 18991190
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effects of infliximab treatment on rheumatoid synovial tissue.
    Tak PP.
    J Rheumatol Suppl; 2005 Mar 15; 74():31-4. PubMed ID: 15742462
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The effect of tumor necrosis factor-α antagonists on arterial stiffness in rheumatoid arthritis: a literature review.
    Dulai R, Perry M, Twycross-Lewis R, Morrissey D, Atzeni F, Greenwald S.
    Semin Arthritis Rheum; 2012 Aug 15; 42(1):1-8. PubMed ID: 22475245
    [Abstract] [Full Text] [Related]

  • 39. Changes in bone mineral density in patients with recent onset, active rheumatoid arthritis.
    Güler-Yüksel M, Bijsterbosch J, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Hulsmans HM, de Beus WM, Han KH, Breedveld FC, Dijkmans BA, Allaart CF, Lems WF.
    Ann Rheum Dis; 2008 Jun 15; 67(6):823-8. PubMed ID: 17644545
    [Abstract] [Full Text] [Related]

  • 40. Short-term effects of the TNFalpha antagonist infliximab on the acute phase reaction and activities of daily life in patients with rheumatoid arthritis.
    Arvidson NG, Larsen A, Aaseth J, Larsson A.
    Scand J Clin Lab Invest; 2007 Jun 15; 67(3):337-42. PubMed ID: 17454848
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.